Pharmidex visits Domainex Unity Campus Site
February 20, 2023
Pharmidex had the pleasure of visiting alliance partner, Domainex, at their new site

Thank you to our alliance partner, Domainex for hosting us at their Unity Campus site recently. It has been great to see our relationship growing and strengthening over the years.

We’re delighted to welcome Gabrielle Georgiou and Dr. Mohammed Ahmad from the University of Hertfordshire as they begin their first experience in a scientific CRO environment here at Pharmidex ! This partnership is an exciting step in fostering early-career scientific talent by offering hands-on exposure to real-world drug discovery and preclinical research. A big thank you to the University of Hertfordshire for partnering with us to support the next generation of innovators. We’re proud to play a role in shaping future leaders in science through meaningful, practical learning opportunities. ๐ฉ๐ฌ ๐จ๐ฌ Welcome to the team, Gabrielle and Mohammed!

At Pharmidex , we offer Brief Access Taste Aversion (BATA) testing, which is a behavioural assay that quantifies how test subjects respond to different compounds or formulations by measuring lick response and aversion. This helps identify: โ
Bitter-tasting APIs โ
Unpalatable excipients โ
The success of taste-masking strategies โ
Formulation-dependent compliance risks Get in touch if you’re developing oral formulations, paediatric drugs, or repurposing bitter APIs, this could be the data your IND package needs.